GW Pharma Pre-Announces Q4 Revenue of $148 Million Ahead of Expectations
GW Pharmaceuticals Provides Preliminary Fourth Quarter and Full-Year 2020 Net Product Sales Results and 2021 Program Milestones Total preliminary net product sales of approximately $148 million for the fourth...